Quantitative benefit-harm assessment for setting research priorities: The example of roflumilast for patients with COPD

Milo A. Puhan, Tsung Yu, Cynthia M. Boyd, Gerben ter Riet

Research output: Contribution to journal › Article › peer-review

10 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Quantitative benefit-harm assessment for setting research priorities: The example of roflumilast for patients with COPD'. Together they form a unique fingerprint.

Medicine & Life Sciences